Publication | Closed Access

Switching Breast Cancer Patients with Progressive Bone Metastases to Third-Generation Bisphosphonates: Measuring Impact Using the Functional Assessment of Cancer Therapy-Bone Pain

Bone DiseaseFunctional AssessmentBone HealthHealth SciencesBreast Cancer PatientsPain MedicineMedicineCancer PainBreast CancerPain ManagementOncologyRadiation OncologyOsteoporosisOrthopaedic SurgeryThird-generation Bisphosphonates